1.0201

3.74% -0.0499

Indaptus Therapeutics Inc (INDP)

Overview News Price History Financials Discussions Forecast

Indaptus Therapeutics Inc stock is traded at $1.0201, with a volume of 284.42K. It is down -3.74% in the last 24 hours and down -59.29% over the past month. Indaptus Therapeutics Inc is a clinical biotechnology company that has developed a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. Its approach is based on the hypothesis that efficient activation of both innate and adaptive immune cells and associated anti-tumor and anti-viral immune responses will require a multi-targeted package of immune system activating signals that can be administered safely intravenously. Its patented technology is composed of single strains of attenuated and killed, non-pathogenic, Gram-negative bacteria, designed to have reduced i.v. toxicity, but largely uncompromised ability to prime or activate many of the cellular components of innate and adaptive immunity. Its candidate, Decoy20 is for patients with solid tumors.

Previous Close:

$1.07

Open:

$1.1

24h Volume:

284.42K

Relative Volume:

0.30

Market Cap:

$141.17M

Revenue:

Net Income/Loss:

$-18.86M

P/E Ratio:

-0.0635

EPS:

-16.054

Net Cash Flow:

$-17.68M

1W Performance:

-13.45%

1M Performance:

-59.29%

6M Performance:

-43.09%

1Y Performance:

-85.53%

1-Day Range:

$1.02

$1.24

1-Week Range:

$1.01

$1.295

52-Week Range:

$0.92

$8.57

Indaptus Therapeutics Inc Stock (INDP) Company Profile

Name

Indaptus Therapeutics Inc

Sector

Healthcare (1089)

Industry

Biotechnology (604)

Phone

(646) 427-2727

Address

3 COLUMBUS CIRCLE, NEW YORK

Employee

Twitter

Next Earnings Date

2026-08-12

Latest SEC Filings

INDP's Discussions on Twitter

Compare INDP vs VRTX, REGN, ARGX, RVMD, ONC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
INDP Indaptus Therapeutics Inc	1.0595	142.57M	0	-18.86M	-17.68M	-16.05
VRTX Vertex Pharmaceuticals Inc	515.49	128.19B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	805.31	82.72B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	993.60	53.26B	4.16B	1.29B	734.26M	19.58
RVMD Revolution Medicines Inc	215.34	43.66B	742.00K	-1.37B	-1.07B	-7.0731
ONC Beone Medicines Ltd Adr	362.60	39.31B	5.76B	514.49M	1.10B	4.4813

Indaptus Therapeutics Inc Stock (INDP) Latest News

Aug 14, 2026

Indaptus Therapeutics Stock Price Forecast. Should You Buy INDP? - StockInvest.us

Aug 14, 2026

Indaptus Therapeutics Inc (NASDAQ: INDP) Share Price, INDP Stock News, INDP Share Price & Updates - Kalkine

Aug 14, 2026

Short Interest in Indaptus Therapeutics, Inc. (NASDAQ:INDP) Declines By 64.1% - MarketBeat

Aug 14, 2026

Aug 13, 2026

Indaptus Therapeutics, Inc. 2Q 2026: Net loss $(1.79M), EPS $(0.02) — 10-Q Summary - TradingView

Aug 13, 2026

Indaptus Therapeutics (Nasdaq: INDP) cuts losses and raises $12M in Q2 - Stock Titan

Aug 13, 2026

Indaptus Q2 Net Loss Narrows to $1.8 Million - Quiver Quantitative

Aug 13, 2026

Indaptus Therapeutics (INDP) slashes R&D costs and bolsters cash after $12M raise - Stock Titan

Aug 13, 2026

Indaptus Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update - marketscreener.com

Aug 13, 2026

Aug 12, 2026